SCHEMBL15701248

SCHEMBL15701248

Cc1cc(NC(=O)C(C)c2cccc(Cl)c2)cc2sc(NC(=O)c3cscn3)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
SENP7 Q9BQF6 2/20 0.40
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 1/20 0.39
ACP1 P24666 1/20 0.39
POLB P06746 2/20 0.38
RORC P51449 1/20 0.38
OPRK1 P41145 2/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
AGTR1 P30556 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CASP3 P42574 1/20 0.36
PSEN1 P49768 2/20 0.36
PSEN2 P49810 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15701252 0.89 GRM4 (0.42) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL15701249 0.89 CYP2C9 (0.47) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL15701165 0.86 ACP1 (0.46) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL15701125 0.86 GRM4 (0.44) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL15701026 0.83 RAB9A (0.48) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL15701283 0.82 CSNK1D (0.52) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL19446717 0.79 RAB9A (0.52) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL15701254 0.79 NPC1 (0.43) NPC1RAB9ASENP7MEN1KMT2A
SCHEMBL15701040 0.79 CYP2C9 (0.45) ALDH1A1MAPTACP1POLBHTT
SCHEMBL15701057 0.78 CASP3 (0.45) NPC1RAB9ASENP7MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2914592-B1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INT (DE) 2017-10-11 EP disclosed
US-9334249-B2 Inhibitors of cytomegalovirus BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-05-10 US disclosed
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-10-08 US disclosed
WO-2014070979-A1 INHIBITORS OF CYTOMEGALOVIRUS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284348-A1 INHIBITORS OF CYTOMEGALOVIRUS CDKN1A, CCNA1, IFNAR1 NPC1 504/4885RAB9A 1015/4885SENP7 3851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.